Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy
- PMID: 19935145
- PMCID: PMC2886667
- DOI: 10.1097/WAD.0b013e3181b5065d
Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy
Abstract
Parkinson disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB) share alpha-synuclein immunoreactivity. These "synucleinopathies" have overlapping signs and symptoms, but less is known about similarities and differences in their cognitive and neuropsychiatric profiles. We compared the cognitive and neuropsychiatric profiles of individuals with PD, MSA, and DLB. Overall, the DLB group showed the most cognitive impairment, the MSA group demonstrated milder impairment, and the PD group was the least cognitively impaired. The DLB and MSA groups showed worse executive function and visuospatial skills than PD, whereas DLB showed impaired memory relative to both PD and MSA. On the neuropsychiatric screening, all groups endorsed depression and anxiety; the DLB group alone endorsed delusions and disinhibition. Consistent with their greater level of cognitive and neuropsychiatric impairment, the DLB group showed the greatest amount of functional impairment on a measure of instrumental activities of daily living (Functional Activities Questionnaire). We found that MSA subjects had cognitive difficulties that fell between the mild deficits of the PD group and the more severe deficits of the DLB group. PD, MSA, and DLB groups have similar neuropsychiatric profiles of increased depression and anxiety. Similar underlying alpha-synuclein pathology may contribute to these shared features.
Similar articles
-
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.JAMA. 2024 Apr 16;331(15):1298-1306. doi: 10.1001/jama.2024.0792. JAMA. 2024. PMID: 38506839 Free PMC article.
-
REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century.Neurology. 2010 Aug 10;75(6):494-9. doi: 10.1212/WNL.0b013e3181ec7fac. Epub 2010 Jul 28. Neurology. 2010. PMID: 20668263 Free PMC article.
-
The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.Acta Neuropathol. 2020 Jun;139(6):977-1000. doi: 10.1007/s00401-020-02157-3. Epub 2020 Apr 30. Acta Neuropathol. 2020. PMID: 32356200 Free PMC article.
-
Diagnosis and Treatment of Cognitive and Neuropsychiatric Symptoms in Parkinson Disease and Dementia With Lewy Bodies.Continuum (Minneap Minn). 2022 Oct 1;28(5):1314-1332. doi: 10.1212/CON.0000000000001151. Continuum (Minneap Minn). 2022. PMID: 36222767 Review.
-
Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment.J Neural Transm Suppl. 2000;(60):335-43. doi: 10.1007/978-3-7091-6301-6_23. J Neural Transm Suppl. 2000. PMID: 11205151 Review.
Cited by
-
The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy.PLoS One. 2015 Oct 2;10(10):e0139773. doi: 10.1371/journal.pone.0139773. eCollection 2015. PLoS One. 2015. PMID: 26431430 Free PMC article.
-
Lactoferrin as a Candidate Multifunctional Therapeutic in Synucleinopathies.Brain Sci. 2025 Apr 6;15(4):380. doi: 10.3390/brainsci15040380. Brain Sci. 2025. PMID: 40309834 Free PMC article. Review.
-
Diagnosis and differential diagnosis of MSA: boundary issues.J Neurol. 2015 Aug;262(8):1801-13. doi: 10.1007/s00415-015-7654-2. Epub 2015 Feb 7. J Neurol. 2015. PMID: 25663409 Review.
-
Alterations in Cognition-Related Cerebello-Cerebral Networks in Multiple System Atrophy.Cerebellum. 2019 Aug;18(4):770-780. doi: 10.1007/s12311-019-01031-7. Cerebellum. 2019. PMID: 31069705
-
The language profile in multiple system atrophy: an exploratory study.J Neural Transm (Vienna). 2021 Aug;128(8):1195-1203. doi: 10.1007/s00702-021-02372-6. Epub 2021 Jul 3. J Neural Transm (Vienna). 2021. PMID: 34216238 Free PMC article.
References
-
- Spillantini MG, Crowther RA, Jakes R, et al. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett. 1998;251:205–208. - PubMed
-
- Nutt JG, Wooten GF. Clinical practice. Diagnosis and initial management of Parkinson's disease. N Engl J Med. 2005;353:1021–1027. - PubMed
-
- Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:94–98. - PubMed
-
- McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–1872. - PubMed
-
- Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain. 2007;130:2770–2788. - PubMed